Reducing Safety-Related Drug Attrition

Contributor: Gareth Waldron
Posted: 11/16/2016

Gareth Waldron is Gareth Waldron, ‎Non-Clinical Safety Lead at Pfizer Neusentis. We spoke to Gareth about about in vitro pharmacological profiling, how it could be implemented to reduce this attrition and the success stories so far.

 

Gerald Clarke            So, Gareth, what are the main causes of safety related drug attrition?

Contributor: Gareth Waldron
Posted: 11/16/2016